Organization (Academic)
Creighton University
ClinicalTrials.gov lists Creighton University as lead sponsor of 127 trials. It has 2 active development programs and 47 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Creighton University, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers Creighton University: 127 lead-sponsored trials and 1 legal-entity registration.
Disease areas (86)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Bone Diseases, Metabolic | 10 |
| Malnutrition | 10 |
| Vitamin D Deficiency | 10 |
| Diabetes Mellitus | 9 |
| Osteoporosis | 9 |
Showing 5 of 86 disease areas.
Trials by start year as sponsor or collaborator (30)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 4 |
| 2024 | 1 |
| 2023 | 3 |
| 2022 | 3 |
| 2021 | 2 |
| 2020 | 2 |
| 2019 | 2 |
| 2018 | 1 |
| 2017 | 6 |
Showing 10 of 30 years.
Prediction, not a registry value: median of 35 months from start to primary completion across 5 trials still running at the 2026-10-09 snapshot; registered median of 19 months across 96 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Active development programs (2)
Shown in this order: max phase, then active trials.
| Drug | Disease area | Max phase | Trials |
|---|---|---|---|
| doxercalciferol capsules, Hectorol® | Bone Diseases, Metabolic | Phase 2/3 | 1 |
| doxercalciferol capsules, Hectorol® | Osteoporosis | Phase 2/3 | 1 |
Approved assets (47)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Calcium-vitamin D3 | 5 |
| OMALIZUMAB | 4 |
| Calcium/Vitamin D | 3 |
| Metoprolol | 3 |
| Hydrochlorothiazide 25 mg | 2 |
Showing 5 of 47 approved assets.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 60% hit target (n=10) | 30% on time (n=10) |
Journals published in (106)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The American journal of clinical nutrition | 9 |
| International journal of sports physical therapy | 7 |
| Annals of internal medicine | 4 |
| Brain injury | 4 |
| Journal of strength and conditioning research | 4 |
Showing 5 of 106 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 65 | 10 | 2025-08-12 |
Financing and grant events (110)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2025-09-17 | NIH grant | 382,394 | Reporter |
| 2025-08-15 | NIH grant | 159,600 | Reporter |
| 2025-07-29 | NIH grant | 430,347 | Reporter |
| 2025-07-14 | NIH grant | 544,279 | Reporter |
| 2025-07-03 | NIH grant | 429,311 | Reporter |
Showing 5 of 110 events.
Latest dated events (309)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-05-25 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-09-17 | NIH grant | Funding rounds and grants (NIH RePORTER + SEC EDGAR) |
| 2025-08-22 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 309 events.
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| CREIGHTON UNIVERSITY | Certificate of waiver | Terminated |
Biomarker capability evidence (53)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| CCNG1 | Trial sponsor | Named in trial inclusion criteria |
| CYP19A1 | Trial sponsor | Named in trial inclusion criteria |
| NPPB | Trial sponsor | Named in trial inclusion criteria |
| SAGE1 | Trial sponsor | Named in trial inclusion criteria |
| TAPBP | Trial sponsor | Named in trial inclusion criteria |
Showing 5 of 53 evidence rows.
Biomarkers this organization publishes on (136)
Shown in this order: most publications first.
Showing 5 of 136 biomarkers.
On Scientist.com
Creighton University is linked to 3 research suppliers in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and organization relationships.
Work with Creighton University School of Medicine Animal Resource Facility on Scientist.com
For prices, more details, or to contact Creighton University School of Medicine Animal Resource Facility, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.